Announcements Trials
Browse Landscape

Status

Completed 7Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Pregnancy Complications 1Leiomyoma 1Estrogen Receptor Positive Breast Cancer 1Endometriosis 1

Interventions

relugolix 1gadoterate meglumine 1epigallocatechin gallate 1Uterine Myomectomy 1Triamcinolone Acetonide 1Triamcinolone 1Tea 1Robotic Surgical Procedures 1Norethindrone Acetate 1Laparoscopy 1Iohexol 1Hysterectomy 1Estradiol 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leiomyoma × Estradiol × Clear all
NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting
530 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡